The Bank of New York Mellon Corporation – Think Buffett/Munger Are On To Something?

Summary BK’s Q4 and FY2018 results released January 16, 2019 reflected a mixed underlying performance. Revenue declined but BK maintained strong expense discipline and benefited from a lower tax rate. BK continues to reward shareholders with $3.3B in common shares repurchased and $1.1B in dividends distributed to common shareholders in FY2018. On December 10th, BK [...]

By |January 16th, 2019|Equity Investing|Comments Off on The Bank of New York Mellon Corporation – Think Buffett/Munger Are On To Something?

Constellation Brands – And This Is Supposed To Impress Me?

On January 9th, the day I posted my most recent article on Constellation Brands (STZ), the outgoing and incoming CEOs appeared on Mad Money following the release of a disappointing 2019 forecast. STZ's current CEO Rob Sands, who will step down in March, stated the response to his company's softer guidance is a "total overreaction" [...]

By |January 13th, 2019|Equity Investing|Comments Off on Constellation Brands – And This Is Supposed To Impress Me?

If It Looks Too Good To Be True It Probably Is

A recent article on a highly followed investor website suggests that two small cap TSX listed companies are appropriate investments for Tax Free Savings Accounts (TFSA). For long-term risk averse investors, neither company would be an appropriate investment. In this article I compare the extent to which both companies have rewarded shareholders with two extremely [...]

By |January 12th, 2019|Equity Investing|Comments Off on If It Looks Too Good To Be True It Probably Is

Constellation Brands – This Is What I Get For Speculating

Summary Constellation Brands (STZ) issued Q3 2019 results and provided lower guidance. Mr. Market did not react positively and STZ’s share price dropped ~12.40% on January 9th. In August 2018 when I purchased January 2019 2 Call $190 contracts I knew I was speculating. Those contracts are now of no value. With STZ’s superior valuation [...]

By |January 9th, 2019|Equity Investing|Comments Off on Constellation Brands – This Is What I Get For Speculating

Berkshire Hathaway – Adding More Shares to the FFJ Portfolio

  Berkshire Hathaway Class B shares (BRK.b) are currently held in the Core Accounts portion of the FFJ Portfolio. I will be transferring additional BRK.b shares to the Side Accounts portion of the FFJ Portfolio and will be acquiring further shares as I view them as being reasonably valued. I anticipate heightened volatility in the [...]

By |January 6th, 2019|Equity Investing|Comments Off on Berkshire Hathaway – Adding More Shares to the FFJ Portfolio

Apple – Put Out the Bucket and Not the Thimble

  Summary On January 3rd, AAPL’s share price sank ~10% after it announced on the 2nd a downward revision in its Q1 2019 guidance. AAPL is, by far, Berkshire Hathaway’s largest equity investment and ~73.3 million shares were purchased between in late 2017 and early 2018 when AAPL was trading in the $163 - $180 [...]

By |January 4th, 2019|Equity Investing|Comments Off on Apple – Put Out the Bucket and Not the Thimble

Paychex – Waiting For Further Pullback

Summary PAYX released Q2 results on December 19th and provided an update on the Oasis Outsourcing Acquisition which was announced on November 26th. Investors may be concerned about the 80+% dividend payout ratio but management has reiterated on several occasions that the company’s positive cash flows have historically allowed it to support its business and [...]

By |December 20th, 2018|Equity Investing|Comments Off on Paychex – Waiting For Further Pullback

Johnson & Johnson – Is It Now Fairly Valued After 15% Pullback?

  Summary Reuters has recently published a story that JNJ has known internally about the presence of asbestos in its talcum powder for decades. Regardless of whether investors feel this is ‘old news’ or not, the fact remains that there are roughly 9,000 – 10,000 pending talc related cases. JNJ is currently appealing a case [...]

By |December 16th, 2018|Equity Investing|Comments Off on Johnson & Johnson – Is It Now Fairly Valued After 15% Pullback?

Korn/Ferry International – Attractively Valued

Summary Korn/Ferry released Q2 results and reported the best top line and bottom line results in the company’s history. Many investors will likely shy away from a KFY investment because of its sub 1% dividend yield and stagnant quarterly dividend. I view shares as being attractively valued and am currently employing a conservative covered Call [...]

By |December 7th, 2018|Equity Investing|Comments Off on Korn/Ferry International – Attractively Valued

CME Group Inc. – Annual Variable Dividend Just Announced

On August 5, 2018 I wrote this article in which I indicated that relying solely on stock screeners to identify investment opportunities has its shortcomings. At the time of that article CME was trading just shy of ~$162 and stock screeners reflected a dividend yield of ~1.73%. Fast forward to December 5 and the stock [...]

By |December 5th, 2018|Equity Investing|Comments Off on CME Group Inc. – Annual Variable Dividend Just Announced
Go to Top